Structure–activity relationships of ketolides vs. macrolides
- 1 January 2001
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 7, 11-17
- https://doi.org/10.1046/j.1469-0691.2001.0070s3011.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The Structural Basis of Ribosome Activity in Peptide Bond SynthesisScience, 2000
- The Complete Atomic Structure of the Large Ribosomal Subunit at 2.4 Å ResolutionScience, 2000
- Macrolide–ketolide inhibition of MLS‐resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNAMolecular Microbiology, 2000
- The macrolide–ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNAMolecular Microbiology, 1999
- Ketolides lack inducibility properties of MLS(B) resistance phenotypeJournal of Antimicrobial Chemotherapy, 1997
- Evaluation of the Intestinal Absorption of Erythromycin in Man: Absolute Bioavailability and Comparison with Enteric Coated ErythromycinPharmaceutical Research, 1995
- The New Macrolide Antibiotics: Azithromycin, Clarithromycin, Dirithromycin, and RoxithromycinAnnals of Pharmacotherapy, 1992
- The development of macrolides: clarithromycin in perspectiveJournal of Antimicrobial Chemotherapy, 1991
- Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNABiochimie, 1987
- Development of Resistance and Cross-Resistance in vitro to Erythromycin, Carbomycin, Spiramycin, Oleandomycin and Streptogramin.Experimental Biology and Medicine, 1956